A Study of Nasopharyngeal Carcinoma From Guangdong

Sun Yat-sen University2,000 enrolled

Overview

This prospective cohort study aims to establish prognostic models, to discover toxicity associated predictors and to validate randomized trials in clinical practice.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Nasopharyngeal Cancer

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * histological confirmed nasopharyngeal carcinoma; * scanned by magnetic resonance imaging from calvaria vertex to clavicles before treatment; * pretreatment Epstein-Barr virus deoxyribonucleic acid copy number is available; * irradiated with intensity-modulated radiotherapy; Exclusion Criteria: * finishing anticancer therapy in two or more hospitals; * pregnancy or lactation; * diagnosed with other sort of cancer before or during the treatment.

Locations (1)

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China

RECRUITING

Outcomes

Primary Outcomes

overall survival

Time frame: 3-years

Secondary Outcomes

Number of participants with treatment-related acute adverse events as assessed by CTCAE v4.0

Time frame: 30-days

Central Contacts

Fang-Yun Xie, MD

CONTACT

+86-02087342618 xiefy@sysucc.org.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.